Literature DB >> 24373940

CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin.

Abhishek Tripathi1, Jeffrey D Davis1, Daniel M Staren1, Brian F Volkman2, Matthias Majetschak3.   

Abstract

Recently, we reported that extracellular ubiquitin functions as another agonist of CXC chemokine receptor (CXCR)4. Whereas the cognate CXCR4 ligand, stromal cell-derived factor (SDF)-1α, is also a CXCR7 agonist, ubiquitin does not bind to CXCR7. Because both ligands are present in the extracellular environment, co-activation of CXCR4 appears to be physiologically relevant. CXCR4 mediated effects of ubiquitin, however, are not well understood and consequences of co-activation of CXCR4 with both ligands are unknown. Utilizing proximity ligation assays and flow cytometry, we detected CXCR4, but not CXCR7, on the cell surface of THP-1 cells, which suggests that confounding effects of CXCR7 are unlikely. Time course and magnitude of reduction of cell surface CXCR4 expression were comparable after stimulation of THP-1 cells with both ligands. SDF-1α was more efficacious than ubiquitin to mobilize Ca(2+). Co-stimulation of THP-1 cells with both ligands resulted in synergistic effects on Ca(2+) fluxes at suboptimal ligand concentrations. Homologous desensitization of Ca(2+) fluxes was detectable with both ligands. SDF-1α pre-stimulation desensitized ubiquitin induced Ca(2+) fluxes, but not vice versa. Effects of SDF-1α and ubiquitin on cAMP levels, Akt and ERK1/2 phosphorylation and chemotactic responses were additive. The chemotactic activities of ubiquitin and SDF-1α were sensitive to AMD3100, pertussis toxin, U73122, LY94002 and U0126. These data suggest that CXCR4 activation with SDF-1α and ubiquitin results in partially synergistic effects on cellular signaling events and in differential effects on receptor desensitization. The ligand ratio that is present in the extracellular environment may contribute to the regulation of CXCR4 mediated functions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CXCL12; CXCR7; Calcium; Chemotaxis; Cyclic AMP

Mesh:

Substances:

Year:  2013        PMID: 24373940      PMCID: PMC4615604          DOI: 10.1016/j.cyto.2013.12.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  14 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

Review 3.  Extracellular ubiquitin: immune modulator and endogenous opponent of damage-associated molecular pattern molecules.

Authors:  Matthias Majetschak
Journal:  J Leukoc Biol       Date:  2010-08-05       Impact factor: 4.962

Review 4.  Regulation of receptor trafficking by GRKs and arrestins.

Authors:  Catherine A C Moore; Shawn K Milano; Jeffrey L Benovic
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

5.  The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions.

Authors:  Vikas Saini; Daniel M Staren; Joshua J Ziarek; Zayd N Nashaat; Edward M Campbell; Brian F Volkman; Adriano Marchese; Matthias Majetschak
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

6.  CXC chemokine receptor 4 is a cell surface receptor for extracellular ubiquitin.

Authors:  Vikas Saini; Adriano Marchese; Matthias Majetschak
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

7.  Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization.

Authors:  M J Orsini; J L Parent; S J Mundell; A Marchese; J L Benovic
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

Review 8.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

9.  Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.

Authors:  Sudarshan Rajagopal; Jihee Kim; Seungkirl Ahn; Stewart Craig; Christopher M Lam; Norma P Gerard; Craig Gerard; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-17       Impact factor: 11.205

10.  CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

Authors:  Angélique Levoye; Karl Balabanian; Françoise Baleux; Françoise Bachelerie; Bernard Lagane
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

View more
  18 in total

1.  Extracellular ubiquitin modulates cardiac fibroblast phenotype and function via its interaction with CXCR4.

Authors:  Stephanie L C Scofield; Christopher R Daniels; Suman Dalal; Jonathan A Millard; Mahipal Singh; Krishna Singh
Journal:  Life Sci       Date:  2018-09-05       Impact factor: 5.037

2.  The Angiotensin Receptor Blocker Losartan Suppresses Growth of Pulmonary Metastases via AT1R-Independent Inhibition of CCR2 Signaling and Monocyte Recruitment.

Authors:  Daniel P Regan; Jonathan W Coy; Kirti Kandhwal Chahal; Lyndah Chow; Jade N Kurihara; Amanda M Guth; Irina Kufareva; Steven W Dow
Journal:  J Immunol       Date:  2019-04-10       Impact factor: 5.422

3.  The role of chemokine receptor 4 and its ligand stromal cell derived factor 1 in breast cancer.

Authors:  Binu Kottakkal Aravindan; Jem Prabhakar; Thara Somanathan; Lakshmi Subhadra
Journal:  Ann Transl Med       Date:  2015-02

4.  Ubiquitin Urine Levels in Burn Patients.

Authors:  Yee M Wong; Heather M LaPorte; Lauren J Albee; Todd A Baker; Harold H Bach; P Geoff Vana; Ann E Evans; Richard L Gamelli; Matthias Majetschak
Journal:  J Burn Care Res       Date:  2017 Jan/Feb       Impact factor: 1.845

5.  Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.

Authors:  Jonathan M Eby; Hazem Abdelkarim; Lauren J Albee; Abhishek Tripathi; Xianlong Gao; Brian F Volkman; Vadim Gaponenko; Matthias Majetschak
Journal:  Mol Cell Biochem       Date:  2017-04-28       Impact factor: 3.396

6.  Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.

Authors:  Abhishek Tripathi; P Geoff Vana; Tanmay S Chavan; Lioubov I Brueggemann; Kenneth L Byron; Nadya I Tarasova; Brian F Volkman; Vadim Gaponenko; Matthias Majetschak
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

7.  α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes.

Authors:  Garrett A Enten; Xianlong Gao; Hannah R Strzelinski; McWayne Weche; Stephen B Liggett; Matthias Majetschak
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-10       Impact factor: 12.779

8.  Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4.

Authors:  Xianlong Gao; You-Hong Cheng; Garrett A Enten; Anthony J DeSantis; Vadim Gaponenko; Matthias Majetschak
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

9.  Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Authors:  Harold H Bach; Yee M Wong; Abhishek Tripathi; Amanda M Nevins; Richard L Gamelli; Brian F Volkman; Kenneth L Byron; Matthias Majetschak
Journal:  Mol Med       Date:  2014-10-13       Impact factor: 6.354

Review 10.  Cardioprotective Potential of Exogenous Ubiquitin.

Authors:  Suman Dalal; Paige L Shook; Mahipal Singh; Krishna Singh
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-10       Impact factor: 3.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.